September 1, 2022

Vesalio’s Neva Net Thrombectomy Device Approved in Europe

September 1, 2022—Vesalio announced European CE Mark approval of the company’s NeVa Net thrombectomy device, which features integrated clot microfiltration technology. Postmarket clinical studies are underway in select markets in Europe and will be followed by broader commercialization in the European marketplace.

According to Vesalio, the NeVa Net stent retriever combines the company’s Drop Zone technology—which has been shown to work on all clot types—with a finely braided microfilter net element integrated into the closed distal tip of the device. The microfilter is designed to keep clot particles from escaping to new or distal territories.

This combination of the company’s technologies is designed to improve recanalization quality, speed, and distal embolization protection, stated Vesalio.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

September 1, 2022

Vesalio’s Neva Net Thrombectomy Device Approved in Europe

Current Issue

Keep In Touch